chlorpropamide has been researched along with c-peptide in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (76.92) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holman, RR; Turner, RC | 2 |
| Friedberg, SJ; Pugh, JA; Ramirez, G; Sawyer, J; Tuley, M; Wagner, ML | 1 |
| Burnett, MA; Davies, EG; Harris, EA; Hosker, JP; Turner, RC | 1 |
| Almeida Neto, JS; Prestes Cesar, F; Toledo e Souza, IT; Wajchenberg, BL | 1 |
| Huupponen, R | 1 |
| Boden, G; Caprio, S; Dayal, VK; Hoeldtke, RD; Mozzoli, MA; Owen, OE; Ray, TK; Reichard, GA; Shuman, CR; Smith, RH | 1 |
| Ashby, JP; Baird, JD; Frier, BM; Nairn, IM | 1 |
| Almér, LO; Johansson, E; Melander, A; Wåhlin-Boll, E | 2 |
| Dreyer, M; Kühnau, J; Rüdiger, HW | 1 |
| Beljic, T; Miric, M | 1 |
| Duarte, AL; Malerbi, DA; Paiva, ES; Wajchenberg, BL | 1 |
1 review(s) available for chlorpropamide and c-peptide
| Article | Year |
|---|---|
Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis.
Topics: Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; MEDLINE; Meta-Analysis as Topic; Middle Aged; Periodicals as Topic; Sulfonylurea Compounds; Tolazamide; Treatment Outcome; United States | 1992 |
3 trial(s) available for chlorpropamide and c-peptide
| Article | Year |
|---|---|
Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis.
Topics: Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; MEDLINE; Meta-Analysis as Topic; Middle Aged; Periodicals as Topic; Sulfonylurea Compounds; Tolazamide; Treatment Outcome; United States | 1992 |
Blood glucose and serum C-peptide after a single chlorpropamide dose.
Topics: Adult; Blood Glucose; C-Peptide; Chlorpropamide; Female; Glucagon; Humans; Insulin; Insulin Secretion; Male; Sulfonylurea Compounds | 1984 |
Improved metabolic control does not reverse left ventricular filling abnormalities in newly diagnosed non-insulin-dependent diabetes patients.
Topics: Adult; Blood Glucose; Blood Pressure; C-Peptide; Chlorpropamide; Cholesterol; Diabetes Mellitus, Type 2; Diet, Diabetic; Echocardiography, Doppler; Female; Follow-Up Studies; Glucagon; Glyburide; Glycated Hemoglobin; Heart Rate; Humans; Male; Middle Aged; Reference Values; Triglycerides; Ventricular Function, Left | 1994 |
10 other study(ies) available for chlorpropamide and c-peptide
| Article | Year |
|---|---|
betacell function during insulin or chlorpropamide treatment of maturity-onset diabetes mellitus.
Topics: Blood Glucose; C-Peptide; Chlorpropamide; Circadian Rhythm; Diabetes Mellitus; Humans; Insulin; Islets of Langerhans | 1978 |
Basal normoglycemia attained with chlorpropamide in mild diabetes.
Topics: Blood Glucose; C-Peptide; Capillary Fragility; Chlorpropamide; Circadian Rhythm; Depression, Chemical; Diabetes Mellitus; Growth Hormone; Humans; Hydroxybutyrates; Insulin, Long-Acting; Lactates; Obesity; Physical Exertion; Triglycerides | 1978 |
Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.
Topics: Aged; Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 2; Glucose; Glyburide; Humans; Hyperglycemia; Insulin; Insulin Resistance; Islets of Langerhans; Middle Aged; Sulfonylurea Compounds | 1985 |
Residual beta-cell function in type II diabetes and evaluation of the hepatic insulin extraction.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Liver; Male; Middle Aged | 1983 |
Improvement of metabolic control in diabetic patients during mebendazole administration: preliminary studies.
Topics: Adult; Benzimidazoles; Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Humans; Insulin; Insulin Resistance; Mebendazole | 1984 |
Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide.
Topics: Adult; Aged; C-Peptide; Chlorpropamide; Diabetes Mellitus; Female; Glucagon; Humans; Insulin; Kinetics; Male; Middle Aged; Peptides | 1981 |
Effects of sulfonylurea on the secretion and disposition of insulin and C-peptide.
Topics: Aged; Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus; Female; Food; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Peptides; Sulfonylurea Compounds | 1981 |
Influence of sulfonylureas on the secretion, disposal and effect of insulin.
Topics: Aged; Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus; Female; Glipizide; Half-Life; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Sulfonylurea Compounds | 1982 |
Chlorpropamide-alcohol flushing is not useful for individual genetic counseling of diabetic patients.
Topics: Adolescent; Adult; Blushing; C-Peptide; Child; Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 1; Ethanol; Genetic Counseling; Humans; Middle Aged; Risk; Tolbutamide | 1980 |
Metabolic effects of dietary sucrose and fructose in type II diabetic subjects.
Topics: Adult; Aged; Blood Glucose; Blood Proteins; Body Weight; C-Peptide; Chlorpropamide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dietary Sucrose; Energy Intake; Female; Fructose; Glyburide; Glycated Serum Proteins; Glycoproteins; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Postprandial Period; Triglycerides | 1996 |